Drawing for XELLIA

USPTO serial 79075436

XELLIA

Reviewed by CopyMark Law Group

Reg. 4381514Status 706Registered
Filing date
Status date
Registration date
Aug 13, 2013
Examiner
HARDY LUDLOW, TARAH KIM
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with XELLIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nicole K. McLaughlin

Nicole K. McLaughlin Duane Morris LLP30 S. 17th StreetPhiladelphia, PA 19103-4196UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry and science, namely, antibiotic, anti-infective, anti-viral, anti-fungal and anti-inflammatory active pharmaceutical ingredients for use in the pharmaceutical and veterinary industry; bulk chemicals for use in the manufacture of pharmaceutical and veterinary preparationsACTIVE—
005Pharmaceutical and veterinary preparations, namely, anti-infective, anti-viral, antibiotic, anti-fungal and anti-inflammatory preparations in bulk and finished dosage form for medical and veterinary purposes, not for use as finished diagnostic preparations and specifically excluding finished pharmaceutical preparations in the form of tablets as well as cardiovascular finished pharmaceutical preparations; sanitary preparations for medical purposes, not for use as finished diagnostic preparations; [ dietetic substances adapted for medical use, namely, foods; ] disinfectants for sanitary and medical purposes; [ preparations for destroying vermin; ] fungicides; herbicidesACTIVE—
010[ Medical apparatus for introducing pharmaceutical preparations into the human body, specifically excluding cardiovascular preparations ]SECTION 71 - CANCELLED—
042Medical and scientific research services in the field of anti-infectives, anti-virals, antibiotics, anti-fungals and anti-inflammatories; pharmaceutical, pharmaceutical ingredient and chemical development services; chemical and pharmaceutical research services and pharmaceutical drug development services [ ; design and development of computer software for use in relation to medical services ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 24, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 21, 2024INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Oct 5, 2024INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 4, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 4, 202471AGREGISTERED-SEC.71 ACCEPTED—
Feb 4, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 1, 2023ES71TEAS SECTION 71 RECEIVED—
Dec 31, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 13, 2022REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Oct 27, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 25, 2020INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Nov 14, 2020INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Nov 14, 2020INPCINVALIDATION PROCESSED—
Nov 4, 2020INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 4, 2020NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Mar 4, 2020C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jan 31, 2020EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Oct 31, 2019RNWLINTERNATIONAL REGISTRATION RENEWED—
Aug 2, 2019PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Jul 30, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 22, 2019ES75TEAS SECTION 71 & 15 RECEIVED—
Jun 10, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 10, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 9, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 18, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 15, 2013FIMPFINAL DISPOSITION PROCESSED—
Nov 13, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 13, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 8, 2013TMBNTTAB RELEASE CASE TO TRADEMARKS—
Jul 8, 2013OP.TOPPOSITION TERMINATED NO. 999999—
Jul 8, 2013OP.DOPPOSITION DISMISSED NO. 999999—
May 14, 2013MAILPAPER RECEIVED—
Oct 5, 2012NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 4, 2011RFNTREFUSAL PROCESSED BY IB—
May 25, 2011OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 17, 2011OP.IOPPOSITION INSTITUTED NO. 999999—
May 16, 2011OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
May 14, 2011OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
May 4, 2011OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 4, 2011OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 17, 2011ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 18, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 29, 2010NPUBNOTICE OF PUBLICATION—
Dec 15, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 14, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 14, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 14, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 13, 2010ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 22, 2010CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jul 16, 2010CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 15, 2010CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 13, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 13, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 10, 2010ALIEASSIGNED TO LIE—
Jun 22, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 12, 2010RFNTREFUSAL PROCESSED BY IB—
Jan 20, 2010RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 20, 2010RFRRREFUSAL PROCESSED BY MPU—
Jan 20, 2010RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 19, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 18, 2010DOCKASSIGNED TO EXAMINER—
Dec 11, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 7, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 4, 2009CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Dec 4, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance